Stay updated on Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page.
Latest updates to the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSeveral links to medical resources and clinical trial information have been removed, including those related to Pembrolizumab and various PubMed articles.SummaryDifference3%
- Check23 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous links to resources related to head and neck cancer, including clinical trial information and various research articles.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page.